Buying medicines from India

1. Understanding the Indian Pharmaceutical Industry

India is home to a thriving pharmaceutical industry known for its advanced manufacturing capabilities, stringent quality standards, and cost-effective production processes. The industry is regulated by the Central Drugs Standard Control Organization (CDSCO) and follows Good Manufacturing Practices (GMP) to ensure the safety, efficacy, and quality of medications.

2. Identifying Reputable Pharmacies and Online Platforms

When purchasing medicines from India, it’s essential to buy from reputable pharmacies and online platforms. Look for pharmacies that are licensed and accredited by regulatory authorities. Additionally, choose online platforms with a track record of reliability, security, and customer satisfaction.

3. Generic vs. Branded Medications

India is renowned for its production of high-quality generic medications, which are bioequivalent to their branded counterparts but available at significantly lower prices. Branded medications from reputed pharmaceutical companies are also available in India. Consider consulting with a healthcare professional to determine the most suitable option for your needs.

4. Prescription Requirements

Some medications may require a prescription from a licensed healthcare provider in India. Ensure that you have a valid prescription when purchasing prescription drugs. Online pharmacies may have different requirements and processes for verifying prescriptions, so familiarize yourself with their policies before placing an order.

5. Shipping and Delivery

When ordering medicines from India, consider factors such as shipping costs, delivery times, and import regulations in your country. Choose shipping methods that offer tracking and insurance for added security. Be aware of customs duties, taxes, and import restrictions that may apply to pharmaceutical imports.

6. Quality Assurance and Safety

Ensure that the medicines you purchase from India meet international quality standards and regulatory requirements. Look for medications manufactured by reputable pharmaceutical companies with a proven track record of quality and safety. Check for proper packaging, labeling, and expiration dates to ensure product integrity.

7. Research and Comparison

Before making a purchase, conduct thorough research and comparison of prices, brands, and product specifications. Compare prices from multiple pharmacies and online platforms to ensure that you’re getting the best value for your money. Pay attention to discounts, promotions, and bulk purchase options that may be available.

8. Consultation with Healthcare Professionals

If you have any questions or concerns about purchasing medicines from India, consult with healthcare professionals, such as pharmacists or physicians. They can provide valuable guidance, recommendations, and assistance in selecting the most appropriate medications and ensuring their safe use.


Buying medicines from India offers a cost-effective and convenient option for accessing high-quality medications. By following this guide and exercising due diligence, you can make informed decisions and purchase medicines that meet your healthcare needs safely and effectively.

Cancer Medicines from India

Introduction to Cancer Medicines from India

India has emerged as a significant player in the global pharmaceutical industry, particularly in the production and export of cancer medicines. With a robust infrastructure, advanced research facilities, and a skilled workforce, Indian pharmaceutical companies have been instrumental in making cancer treatment more accessible and affordable worldwide.

Quality and Safety Standards

Cancer medicines manufactured in India adhere to stringent quality and safety standards set by regulatory authorities such as the Central Drugs Standard Control Organization (CDSCO) and the World Health Organization (WHO). These standards ensure that medicines meet the highest levels of efficacy, safety, and quality.

Wide Range of Medications

Indian pharmaceutical companies offer a wide range of cancer medications, including chemotherapy drugs, targeted therapies, immunotherapies, and supportive care medications. These medications are available in various formulations, strengths, and dosage forms to meet the diverse needs of patients.

Affordability and Accessibility

One of the key advantages of cancer medicines from India is their affordability. Indian pharmaceutical companies produce high-quality medications at a fraction of the cost compared to their counterparts in developed countries. This affordability makes cancer treatment more accessible to patients worldwide, especially in low- and middle-income countries.

Innovation and Research

Indian pharmaceutical companies are actively involved in research and development (R&D) initiatives to discover and develop new cancer treatments. Collaborations with academic institutions, research organizations, and international partners contribute to innovation in cancer drug discovery and development.

Global Reach and Export

Indian cancer medicines have a significant global reach, with exports to various countries across the globe. These medicines play a vital role in addressing the growing demand for affordable cancer treatment options worldwide. Indian pharmaceutical companies comply with international regulatory requirements and standards to ensure the quality and safety of exported medications.

Patient Support and Care

In addition to manufacturing and exporting cancer medicines, Indian pharmaceutical companies also provide patient support programs and initiatives. These programs aim to enhance patient access to treatment, improve medication adherence, and provide educational resources and support services for cancer patients and their families.


Cancer medicines from India represent a vital component of global cancer care, offering high-quality, affordable treatment options to patients worldwide. With a commitment to innovation, quality, and patient care, Indian pharmaceutical companies continue to make significant contributions to the fight against cancer on a global scale.

Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India

Sun Pharma said one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing LDL cholesterol.

The company will launch the drug under the brand name Brillo.

The drug is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents.

It is indicated for people who have an inherited genetic disorder that causes high cholesterol levels or established heart disease where cholesterol levels remain high, despite lifestyle changes and the use of maximum tolerated dose of statins.

”Sun Pharma is the leader in the cardiovascular segment and a pioneer in lipid-lowering therapy in India. In line with our commitment to introducing novel products, we are launching this first-in-class oral drug Brillo,” Sun Pharma CEO – India Business Kirti Ganorkar said in a statement.

The product is a novel treatment option that will help manage high LDL cholesterol in patients with heart diseases, a condition which is growing at an alarming rate, he added.

Roche Pharma launches PHESGO in India for the treatment of HER-2 positive breast Cancer

It is also the world’s first subcutaneous therapy for breast cancer that offers faster, more comfortable administration of Perjeta and Herceptin under the skin in just minutes, compared to multiple hours with standard intravenous administration, the pharma company stated.

New Delhi : Roche Pharma on Thursday announced the launch of PHESGO, the fixed dose
combination of two monoclonal antibodies in oncology for the treatment of HER-2 positive
breast cancer now available in India. The drug combines two proven blockbuster monoclonal
antibodies: Perjeta® (pertuzumab) and Herceptin® (trastuzumab) in a single vial for
subcutaneous administration. The subcutaneous injection in combination with intravenous (IV)
chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer.

Informing that this is the first time that Roche Pharma has combined two monoclonal antibodies
that can be administered by a single SC injection, the company also stated that it is also the
world’s first subcutaneous therapy for breast cancer that offers faster, more comfortable
administration of Perjeta and Herceptin under the skin in just minutes, compared to multiple
hours with standard intravenous administration.

“It is administered as a single injection just under the skin in the thigh. Takes a few minutes
compared to hours with IV formulations for each round of treatment, thus reducing chair time for
patients by 90 per cent. Provides a faster, more convenient, and less invasive means to receive
breast cancer therapy Faster administration through PHESGO gives the confidence and frees
up time for everyone (patients, caregivers, doctors and paramedical staff), shorter
appointments, freeing up time of HCPs to treat more patients,” the company said in a statement.

Add to cart